CompletedRelapsing and progressiveNCT01436838

What it found

No result found

We found no results in the registry or in papers.

This trial finished 11 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

What it measured

Main measures

  • Adherence to Betaferon treatment: proportion of patients adhering to Betaferon treatment

    at 6, 12, 18 and 24 months

    Quality of life (reported by participants)

Other measures (2)

  • Ways of Coping Questionnaire (WCQ)

    at 6, 12, 18 and 24 months

  • Hospital Anxiety and Depression Scale (HAD)

    at 6, 12, 18 and 24 months

    Mood and sleep

Who could take part

Relapsing and progressive · 18 to 75

Inclusion Criteria: * Relapsing-remitting multiple scelrosis (RRMS) and secondary progressive multiple sclerosis (SPMS) patients * Having Betaferon treatment, including patients who are * First time using; or * Re-staring; or * Switching from other diseases modifying drugs (DMDs) Exclusion Criteria: * Known or newly identified contraindication for administration of Betaferon according to Summary of Product Characteristic (SmPC).

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Non-adherence reduces treatment benefit and can bias the assessment of treatment efficacy thereby involving safety risks for the patient and influencing health cost-effectiveness. This observational study will concentrate upon the role of MS nurses in influencing adherence. This study will examine the influence of initial and subsequent periodic nurse interviews which aim to improve adherence to Betaferon® treatment.

Loading reviews and guidelines…

Related trials

History

    1. Started

      Mar 2012

    2. Main results due

      Sept 2015

    3. Finished

      Dec 2015

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error